Sector: MedicalACHN (NASDAQ: ACHN)
Headlines
- Achillion to Present at Three Upcoming Conferences
Oct 29, 2009 04:01 PM | ACHN
- Achillion Completes Phase 1a Trial of ACH-1625; Begins Dosing in Phase 1b Segment With HCV-Infected Patients
Sep 28, 2009 07:02 AM | ACHN
- Achillion to Present At the Thomas Weisel Partners Annual Healthcare Conference
Sep 03, 2009 04:01 PM | ACHN
- FDA Calendar Updates: Genzyme FDA Woes Benefit Protalix, Shire
Jul 31, 2009 05:12 PM | ACHN, GENZ, GILD, PLX, SHPGY
- In Search of Healthcare Diamonds In The Rough
Jan 12, 2009 12:57 AM | ACHN, AKRX, BPA, CYNO, DNA, ENDP
- Look For Laggards After Latest Market Rally
Dec 09, 2008 09:14 AM | ACAD, ACHN, ADLR, DRYS, HITK, ICGN
- Eyeing Opportunities In Micro-Cap Bio-Pharma Index
Dec 02, 2008 09:54 AM | ACHN, ACUS, ADLR, AKRX, BDSI, BMY
- Achillion Pharma: Funding in Place to Advance HCV Pipeline
Nov 24, 2008 11:28 PM | ACHN, GILD, GNLB, GSK
- Earnings Report: 02/27/2008
Feb 27, 2008 07:51 PM | ACHN, AER, AHT, AIRN, ALTH, AMED
- UPDATE: SEC Sues Blue Bottle; Says Co Hacked News Releases
Feb 26, 2007 01:25 PM | AB, ACHN, BJ, BRC, CAI, HOS
- Achillion Reports Third Quarter Results
Nov 06, 2009 07:51 AM | ACHN, GILD
- Achillion to Present At the Canaccord Adams 29th Annual Global Growth Conference
Aug 03, 2009 07:00 AM | ACHN
- Achillion Reports Second Quarter and Six Month Financial Results
Jul 30, 2009 04:03 PM | ACHN
- Achillion Enters $15 Million Standby Equity Distribution Agreement
Jul 06, 2009 07:01 AM | ACHN
- Achillion Announces First-in-Human Dosing of ACH-1625 for Treatment of Hepatitis C
Jun 29, 2009 07:00 AM | ACHN
- Achillion to Present At Upcoming Conferences
Jun 02, 2009 07:02 AM | ACHN
- Achillion Reports First Quarter Financial Results and Provides Pipeline Update
May 15, 2009 09:26 AM | ACHN, GILD
- Achillion Granted U.S. Patent for NS4A Antagonists in Hepatitis C
Apr 16, 2009 02:35 PM | ACHN
- Achillion to Present At the Canaccord Adams Hepatitis C Conference
Apr 03, 2009 02:23 PM | ACHN
- Achillion Reports 2008 Fourth Quarter and Year-End Financial Results
Mar 25, 2009 04:00 PM | ACHN
- Form 4 Truitt Joseph For: Jan 05 (10K)
Jan 07, 2009 05:08 PM
- Form 3 Truitt Joseph For: Jan 05 (10K)
Jan 07, 2009 05:08 PM
- Form 4 INVESTOR GROWTH CAPITAL For: Dec 18 (10K)
Dec 22, 2008 04:31 PM
- Form 4 ACHILLION PHARMACEUTICAL For: Dec 15 Filed by: Shah Gautam (10K)
Dec 17, 2008 08:33 PM
- Form 4 ACHILLION PHARMACEUTICAL For: Dec 15 Filed by: Olek Elizabeth A (10K)
Dec 17, 2008 08:33 PM
- Form 4 ACHILLION PHARMACEUTICAL For: Dec 15 Filed by: KISHBAUCH MICHAEL D (10K)
Dec 17, 2008 08:33 PM
- Form 4 ACHILLION PHARMACEUTICAL For: Dec 15 Filed by: Fenton Mary Kay (10K)
Dec 17, 2008 08:33 PM
- Form 4 ACHILLION PHARMACEUTICAL For: Dec 15 Filed by: Deshpande Milind (10K)
Dec 17, 2008 08:30 PM
- Form 4 ACHILLION PHARMACEUTICAL For: Dec 15 Filed by: Liotta Dennis (10K)
Dec 17, 2008 08:30 PM
- Form 3 ACHILLION PHARMACEUTICAL For: Dec 15 Filed by: Liotta Dennis (10K)
Dec 17, 2008 08:30 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ACHN
|
Compare to S&P
|
| YTD |
182.35 %
|
133.23 %
|
| 4 Weeks |
2.13 %
|
1.59 %
|
| 12 Weeks |
6.67 %
|
0.10 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 25.81 %
|
|
Sales Growth in Last Quarter: -93.72 %
|
|
Sales Growth in Last Quarter: -97.22 %
|
|
